Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab &

See also
Status	Clinical Trial	Phase
Terminated	`NCT02764151` - First in Patient Study for PF-06840003 in Malignant Gliomas	Phase 1
Completed	`NCT02526017` - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers	Phase 1
Completed	`NCT00953121` - Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)	Phase 2
Completed	`NCT00766467` - A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas	Phase 2
Active, not recruiting	`NCT03233204` - Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)	Phase 2
Recruiting	`NCT05045027` - Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma	Early Phase 1
Completed	`NCT02507583` - Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma	Phase 1
Completed	`NCT04109209` - Psychological Intervention For Brain Tumor Caregivers	N/A
Recruiting	`NCT04937413` - The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation	Early Phase 1
Completed	`NCT03615404` - Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma	Phase 1
Active, not recruiting	`NCT04175301` - Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.	Phase 2
Terminated	`NCT02659800` - Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas	Phase 1
Active, not recruiting	`NCT02323880` - Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas	Phase 1
Completed	`NCT00782756` - Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma	Phase 2
Terminated	`NCT02855086` - Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery	Phase 1/Phase 2
Completed	`NCT02861222` - Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma	Phase 1
Completed	`NCT00634231` - A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors	Phase 1
Completed	`NCT01792505` - Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma	Phase 1
Completed	`NCT00190723` - A Study of LY317615 in Patients With Brain Tumors	Phase 2
Recruiting	`NCT04323046` - Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults	Phase 1

NCT number	NCT02313272
Study type	Interventional
Source	H. Lee Moffitt Cancer Center and Research Institute
Contact
Status	Completed
Phase	Phase 1
Start date	July 28, 2015
Completion date	August 9, 2021

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms